Inhibition of inflammatory cells delays retinal degeneration in experimental retinal vein occlusion in mice

Jovanovic, Joël; Liu, Xuan; Kokona, Despina; Zinkernagel, Martin S.; Ebneter, Andreas (2020). Inhibition of inflammatory cells delays retinal degeneration in experimental retinal vein occlusion in mice. GLIA, 68(3), pp. 574-588. Wiley-Blackwell 10.1002/glia.23739

[img]
Preview
Text
Jovanovic_et_al-2019-Glia.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. © 2019 The Authors. Glia published by Wiley Periodicals, Inc.

Download (6MB) | Preview

The role of microglia in retinal inflammation is still ambiguous. Branch retinal vein occlusion initiates an inflammatory response whereby resident microglia cells are activated. They trigger infiltration of neutrophils that exacerbate blood–retina barrier damage, regulate postischemic inflammation and irreversible loss of neuroretina. Suppression of microglia-mediated inflammation might bear potential for mitigating functional impairment after retinal vein occlusion (RVO). To test this hypothesis, we depleted microglia by PLX5622 (a selective tyrosine kinase inhibitor that targets the colony-stimulating factor-1 receptor) in fractalkine receptor reporter mice (Cx3cr1gfp/+) subjected to various regimens of PLX5622 treatment and experimental RVO. Effectiveness of microglia suppression and retinal outcomes including retinal thickness as well as ganglion cell survival were compared to a control group of mice with experimental vein occlusion only. PLX5622 caused dramatic suppression of microglia. Despite vein occlusion, reappearance of green fluorescent protein positive cells was strongly impeded with continuous PLX5622 treatment and significantly delayed after its cessation. In depleted mice, retinal proinflammatory cytokine signaling was diminished and retinal ganglion cell survival improved by almost 50% compared to nondepleted animals 3 weeks after vein occlusion. Optical coherence tomography suggested delayed retinal degeneration in depleted mice. In summary, findings indicate that suppression of cells bearing the colony-stimulating factor-1 receptor, mainly microglia and monocytes, mitigates ischemic damage and salvages retinal ganglion cells. Blood–retina barrier breakdown seems central in the disease mechanism, and complex interactions between different cell types composing the blood–retina barrier as well as sustained hypoxia might explain why the protective effect was only partial.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology

Graduate School:

Graduate School for Cellular and Biomedical Sciences (GCB)

UniBE Contributor:

Kokona, Despina, Zinkernagel, Martin Sebastian, Ebneter, Andreas

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0894-1491

Publisher:

Wiley-Blackwell

Language:

English

Submitter:

Andreas Ebneter

Date Deposited:

04 Nov 2019 09:57

Last Modified:

02 Mar 2023 23:32

Publisher DOI:

10.1002/glia.23739

PubMed ID:

31652020

Uncontrolled Keywords:

blood–retina barrier, inflammation, ischemia, microglia, receptor tyrosine kinase inhibitor, retinal ganglion cell, retinal vein occlusion

BORIS DOI:

10.7892/boris.134278

URI:

https://boris.unibe.ch/id/eprint/134278

Actions (login required)

Edit item Edit item
Provide Feedback